MedTrace Logo

Reliability of Consumer Sleep Trackers in Patients Suffering From Obstructive Sleep Apnea Syndrome

NCT02967367 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2020-03-24

Study results available
· View outcomes & findings →

Summary

During last years, numerous sleep trackers have been commercialized. They are intended to give indications about sleep quality/duration in order to give people an internet-based feedback about their own sleep.

For clinical and research purposes, tri-axial accelerometers/multi-sensors devices are used routinely to assess objective sleep quality/patterns. Their use is also validated to estimate sleep in obstructive sleep apnea syndrome (OSA).

The purpose of the present study is to compare the accuracy of consumer-level sleep trackers and validated tools to measure sleep in OSA patients.

Conditions

  • Obstructive Sleep Apnea Syndrome

Interventions

DEVICE

Jawbone sleep tracker

During one night of polysomnographic recording, investigators are going to place these 3 accelerometers on the wrist of the patient

DEVICE

Withings sleep tracker

During one night of polysomnographic recording, investigators are going to place these 3 accelerometers on the wrist of the patient

DEVICE

BodyMedia Sense Wear accelerometer

During one night of polysomnographic recording, investigators are going to place these 3 accelerometers on the wrist of the patient

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Saint Pierre

    lead OTHER

Principal Investigators

  • Marie Bruyneel, MD PhD · Centre Hospitalier Universitaire Saint Pierre

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02967367 on ClinicalTrials.gov